To evaluate the potential application of computed tomography (CT) radiomics in the prediction of BRCA1-associated protein 1 (BAP1) mutation status in patients with clear-cell renal cell carcinoma (ccRCC). The gene discussed is BAP1; the disease is nonpapillary renal cell carcinoma.